EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

cGAS–STING signalling in cancer: striking a balance with chromosomal instability

Bruno Beernaert iD, Eileen E Parkes iD

Biochemical Society Transactions · 26.04.2023 · 51 (2) · 539-555

DOI: 10.1042/bst20220838 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, online erschienen am 06.03.2023. Verfasst von Bruno Beernaert und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, U.K. Hauptthemen laut MEDLINE: Chromosomal Instability, Neoplasms. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chromosomal instability (CIN) is a hallmark of cancer that drives tumour evolution. It is now recognised that CIN in cancer leads to the constitutive production of misplaced DNA in the form of micronuclei and chromatin bridges. These structures are detected by the nucleic acid sensor cGAS, leading to the production of the second messenger 2′3′-cGAMP and activation of the critical hub of innate immune signalling STING. Activation of this immune pathway should instigate the influx and activation of immune cells, resulting in the eradication of cancer cells. That this does not universally occur in the context of CIN remains an unanswered paradox in cancer. Instead, CIN-high cancers are notably adept at immune evasion and are highly metastatic with typically poor outcomes. In this review, we discuss the diverse facets of the cGAS–STING signalling pathway, including emerging roles in homeostatic processes and their intersection with genome stability regulation, its role as a driver of chronic pro-tumour inflammation, and crosstalk with the tumour microenvironment, which may collectively underlie its apparent maintenance in cancers. A better understanding of the mechanisms whereby this immune surveillance pathway is commandeered by chromosomally unstable cancers is critical to the identification of new vulnerabilities for therapeutic exploitation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chromosomal InstabilityNeoplasmsHumansImmunity, InnateInflammationNucleotidyltransferasesSignal TransductionTumor MicroenvironmentCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseSTING Protein

Stichwörter der Autor:innen

DNA synthesis and repaircGAS-STINGchromosomal instabilityimmunosurveillanceinnate immunity

Substanzen

NucleotidyltransferasescGAS protein, humanCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseSTING1 protein, humanSTING Protein

Autor:innen und Institutionen

  • Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, U.K.

ORCID-Profile: Bruno Beernaert, Eileen E Parkes

Förderung

  • Wellcome Trust
  • Cancer Research UK

Zitieren

APA

Beernaert, B., & Parkes, E. E. (2023). cGAS–STING signalling in cancer: striking a balance with chromosomal instability. Biochemical Society Transactions, 51(2), 539-555. https://doi.org/10.1042/bst20220838

Vancouver

Beernaert B, Parkes EE. cGAS–STING signalling in cancer: striking a balance with chromosomal instability. Biochemical Society Transactions. 2023;51(2):539-555. doi:10.1042/bst20220838

BibTeX
@article{Beernaert2023,
  author = {Beernaert, Bruno and Parkes, Eileen E},
  title = {cGAS–STING signalling in cancer: striking a balance with chromosomal instability},
  journal = {Biochemical Society Transactions},
  year = {2023},
  volume = {51},
  number = {2},
  pages = {539--555},
  doi = {10.1042/bst20220838}
}
Kostenlos starten →